AROMATIC THIOETHER LIVER X-RECEPTOR MODULATORS

WIPO Patent Application WO2003059874

A3

The present invention is directed to selective LXR modulators, small molecule compounds corresponding to Formula (I) and is further directed to a process of treating a condition in a mammal that is modulated by LXR using a therapeutically effective dose of a compound of Formula (I).

WO/1996/033678	TRIACETIN AS A TRANSDERMAL PENETRATION ENHANCER
JP2013528439	Multi-phase soft gel capsule, its equipment and method
WO/2015/046388	DRUG FOR PREVENTING, TREATING OR PREVENTING METASTASIS OF GIANT CELL TUMOR THAT OCCURS IN BONE OR SOFT PARTS, CHONDROSARCOMA, OR OSTEOSARCOMA, LOCAL INJECTION FOR ARTERIAL EMBOLIZATION, AND ARTIFICIAL BONE

CHANDRAKUMAR NIZAL S (US)
DALTON CHRISTOPHER R (US)
MALECHA JAMES W (US)
TOLLEFSON MICHAEL B (US)
VANCAMP JENNIFER ANN (US)
COX PHILLIP B (US)

PCT/US2002/041083

April 01, 2004

December 23, 2002

Click for automatic bibliography generation  

PHARMACIA CORP (US)
CHANDRAKUMAR NIZAL S (US)
DALTON CHRISTOPHER R (US)
MALECHA JAMES W (US)
TOLLEFSON MICHAEL B (US)
VANCAMP JENNIFER ANN (US)
COX PHILLIP B (US)

A61K31/167; A61K31/352; A61K31/357; A61K31/36; A61K31/366; A61K31/381; A61K31/4402; A61P1/16; A61P3/06; A61P3/10; A61P9/10; A61P25/28; A61P43/00; C07C323/41; C07C323/42; C07D213/32; C07D311/08; C07D311/16; C07D317/56; C07D317/62; C07D317/64; C07D319/08; C07D333/38; C07D333/40; C07D407/12; C07D409/12; (IPC1-7): C07D409/12; C07D333/38; C07D317/62; C07D319/08; C07D311/16; C07C323/41; C07D407/12; C07C323/42; C07D317/56; C07D213/32; C07D317/64; A61K31/167; A61K31/357; A61K31/36; A61K31/381

WO2001060818A1	2001-08-23
WO2002046181A2	2002-06-13

US3378586A	1968-04-16
US5690904A	1997-11-25
EP0453658A2	1991-10-30

H. OKAMOTO ETAL, NATURE, vol. 406, no. 6792, 2000, pages 203 - 207, XP002266120
"Chemical Abstracts Service Registry Handbook, 2000 Supplement; ISSN: 0093-058X; CAS Registry Number 256285-97-9 through 260528-41-4", 2000, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, XP002266173
DATABASE CAPLUS AMERICAN CHEMICAL SOCIETY; 12 May 1984 (1984-05-12), XP002266127, retrieved from STN Database accession no. 1973:478762
J.A. CONNOR ET AL, J. CHEM. SOC. PERKIN TRANS. 1, no. 4, 1990, pages 1127 - 1132, XP001021533
R.N. PRASAD ET AL, CAN. J. CHEM., vol. 44, no. 11, 1966, pages 1247 - 1258, XP001027730
DATABASE CAPLUS AMERICAN CHEMICAL SOCIETY; 22 April 2001 (2001-04-22), XP002266129, retrieved from STN Database accession no. 1957:98876
E. MOUNETOU ET AL, J. LABELLED COMP. RADIOPHARM., vol. 41, no. 3, 1998, pages 181 - 189, XP002266165
DATABASE CAPLUS AMERICAN CHEMICAL SOCIETY; 12 May 1984 (1984-05-12), XP002266128, retrieved from STN Database accession no. 1980:471730
R. SPECKLIN ET AL, BULL. SOC. CHIM. FR., 1951, pages 621 - 626, XP000616273
"Chemical Abstracts Service Registry Handbook, 2000 Supplement; ISSN: 0093-058X; CAS Registry Number 271534-00-0 through 276887-31-1", 2001, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO,US, XP002266300

View/Download PDF      PDF Help

Previous Patent: AVB3 AND AVB5 INTEGRIN ANTAGONISTS AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH AV...

Next Patent: DERIVATIVES OF $g(a)-PHENYLTHIOCARBOXYLIC AND $g(a)-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATM...